Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Susie Long, Veronika Bachanova, Qing Cao, Christen L. Ebens, Troy C. Lund, Margaret L MacMillan, Alex Hoover
Model-predicted fludarabine exposure and outcomes after tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia. // Cytotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S1465324926009485?dgcid=rss_sd_all
Model-predicted fludarabine exposure and outcomes after tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia. Cytotherapy. https://www.sciencedirect.com/science/article/pii/S1465324926009485?dgcid=rss_sd_all
“Model-predicted fludarabine exposure and outcomes after tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia.” Cytotherapy.
@article{article42827,
title = {Model-predicted fludarabine exposure and outcomes after tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia},
journal = {Cytotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S1465324926009485?dgcid=rss_sd_all}
}